| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |